Loading patent…
AssigneesJ. Craig Venter Institute, Inc., Novartis AG
InventorsSean C. Daugherty, Julie C. Dunning Hotopp, David R. Riley, Samuel V. Angiuoli, Heather Huot Creasy, Todd H. Creasy, Herve Tettelin, Duccio Medini, Emilio Siena, Sonia Budroni, Maria Scarselli
Estimating the term…
Polypeptides comprising Neisseria meningitidis amino acid sequences. Over 36000 meningococcal polypeptide sequences are disclosed. The invention also provides related polypeptides, nucleic acids, antibodies and methods. These can all be usedin medicine for treating or preventing disease and/or infection caused by N. meningitidis, such as meningococcal meningitis.
A polypeptide comprising an amino acid sequence that has at least 75% sequence identity to one or more of SEQ ID NOs:
A polypeptide comprising a fragment of at least 7 consecutive amino acids from one or more of SEQ ID NOS:
A nucleic acid comprising a nucleotide sequence that has at least 75% sequence identity to one or more of SEQ ID NOS:
A nucleic acid comprising a fragment of 10 or more consecutive nucleotides from one or more of SEQ ID NOS:
Dependencies are inferred from the claim text.